(19)
(11) EP 1 365 761 A1

(12)

(43) Date of publication:
03.12.2003 Bulletin 2003/49

(21) Application number: 00989288.6

(22) Date of filing: 18.12.2000
(51) International Patent Classification (IPC)7A61K 31/44, A61K 31/55, A61P 9/00, A61P 9/02, A61P 9/04, A61P 9/10, A61P 9/12, A61P 11/00, A61P 27/00, A61P 43/00
// A61K31:44, A61K31:55
(86) International application number:
PCT/US0034/246
(87) International publication number:
WO 0204/9645 (27.06.2002 Gazette 2002/26)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(71) Applicant: Novartis AG
4056 Basel (CH)

(72) Inventors:
  • DALEY, William, Lionel
    Morris Plains, NJ 07950 (US)
  • WEBB, Randy, Lee
    Flemington, NJ 08822 (US)

(74) Representative: Grubb, Philip William 
Novartis AG,Corporate Intellectual Property
4002 Basel
4002 Basel (CH)

   


(54) THERAPEUTIC COMBINATION OF AMLODIPINE AND BENAZEPRIL